Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-03-15+99,000→ 101,130 total - Award
Stock Option (right to buy)
2024-03-15+198,000→ 198,000 totalExercise: $3.00Exp: 2034-03-14→ Common Stock (198,000 underlying)
Holdings
- 97,058(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
- 1,015,766(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F2]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F3]Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- [F4]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.
- [F5]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.